635 results

• Off-Label Antipsychotic Use Exposes Patients to Bad Side Effects: Study

  October 6, 2011

  Staff Writers

  The potential side effects of atypical antipsychotics may do more harm than good when used off-label, according to the findings...

• Yasmin, Yaz Blood Clot Concerns To Be Reviewed by FDA Panel

  September 28, 2011

  Staff Writers

  A federally-funded study suggests that side effects of Yaz and Yasmin may carry a 150% increased risk of blood clots...

• Antidepressant and Blood Thinner Combo May Increase Risk for Bleeding

  September 28, 2011

  Staff Writers

  Some antidepressants could increase the risk of serious and potentially life-threatening bleeding among patients taking Plavix, aspirin and other anti-clotting...

• Side Effects of Multaq Lead to Restrictions in Europe, US Likely to Follow

  September 23, 2011

  Staff Writers

  Concerns over potential side effects of Multaq, a relatively new heart drug, have lead European health officials to restrict use...

• Recalled Heart Surgery Drug Trasylol Allowed Back on Market in Canada

  September 22, 2011

  Staff Writers

  Canadian health officials are allowing the recalled heart surgery drug Trasylol back on the market in the country, but stress...

• Avandia Statute of Limitations Motion to Dismiss Denied by MDL Judge

  September 20, 2011

  Staff Writers

  A federal judge has rejected an attempt by GlaxoSmithKline to throw out dozens of Avandia lawsuits, which the drug maker...

• Brain Stent Less Effective at Stroke Treatment Than Plavix and Aspirin: Study

  September 15, 2011

  Staff Writers

  A new study by U.S. researchers finds that using Stryker’s Wingspan brain stent in stroke victims may be more dangerous...

• Antipsychotic Side Effects Not Being Monitored in Most Patients: Study

  August 29, 2011

  Staff Writers

  Individuals taking antipsychotic medications need more medical monitoring due to increased health risks, according to new research. 

• Multaq Liver Failure Case Highlighted in Medical Journal

  August 22, 2011

  Staff Writers

  A recently published case report examines the risk of liver failure from Multaq, a relatively new heart drug that has...

• Discovery in Yasmin and Yaz Litigation Expanded Beyond Bellwether Cases

  July 26, 2011

  Staff Writers

  The judge presiding over all federal Yaz lawsuits and Yasmin lawsuits has expanded the scope of discovery in the litigation...